Literature DB >> 10500304

Negative regulation of cytokine signaling: STAT-induced STAT inhibitor.

T Naka1, M Fujimoto, T Kishimoto.   

Abstract

The growth and differentiation of cells that make up multicellular entities such as the blood and immune systems are under the control of glycoprotein mediators known as cytokines. These cytokines bind to membrane receptors on the cell surface and initiate a signaling cascade that ends with the transcription of specific sets of genes within the cell nucleus. Although knowledge is accumulating concerning the intracellular signal pathways that are activated by cytokines, little is known about inhibition of cytokine signals. This review will focus on the negative regulation of the Janus tyrosine kinase (JAK)/signal transducers and activators of transcription (STAT) signaling pathway by proteins related to STAT-induced STAT inhibitor-1 (SSI-1).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500304     DOI: 10.1016/s0968-0004(99)01454-1

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  22 in total

1.  IL-6 transgenic mouse model for extraosseous plasmacytoma.

Authors:  Alexander L Kovalchuk; Joong Su Kim; Sung Sup Park; Allen E Coleman; Jerrold M Ward; Herbert C Morse; Tadamitsu Kishimoto; Michael Potter; Siegfried Janz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways.

Authors:  H Yasukawa; M Hoshijima; Y Gu; T Nakamura; S Pradervand; T Hanada; Y Hanakawa; A Yoshimura; J Ross; K R Chien
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 3.  Dendritic cells and tumor microenvironment: a dangerous liaison.

Authors:  Ingo Fricke; Dmitry I Gabrilovich
Journal:  Immunol Invest       Date:  2006       Impact factor: 3.657

4.  Refinement of cytokine use in the in vitro expansion of erythroid cells.

Authors:  Ken-Ichi Miharada; Takashi Hiroyama; Kazuhiro Sudo; Toshiro Nagasawa; Yukio Nakamura
Journal:  Hum Cell       Date:  2006-02       Impact factor: 4.174

5.  Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.

Authors:  Feng Hong; Barbara Jaruga; Won Ho Kim; Svetlana Radaeva; Osama N El-Assal; Zhigang Tian; Van-Anh Nguyen; Bin Gao
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

6.  Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade.

Authors:  David S Park; Hyangkyu Lee; Philippe G Frank; Babak Razani; Andrew V Nguyen; Albert F Parlow; Robert G Russell; James Hulit; Richard G Pestell; Michael P Lisanti
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

7.  Negative regulation of FAK signaling by SOCS proteins.

Authors:  Enbo Liu; Jean-François Côté; Kristiina Vuori
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

8.  Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation.

Authors:  Yoh-Ichi Seki; Katsuhiko Hayashi; Akira Matsumoto; Noriyasu Seki; Jun Tsukada; John Ransom; Tetsuji Naka; Tadamitsu Kishimoto; Akihiko Yoshimura; Masato Kubo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

9.  Expression of SOCS-1 in the liver tissues of chronic hepatitis B and its clinical significance.

Authors:  Zhi-Xin Zhao; Qing-Xian Cai; Xiao-Mou Peng; Yu-Tian Chong; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

10.  Association of interleukin-6 signalling with the muscle stem cell response following muscle-lengthening contractions in humans.

Authors:  Bryon R McKay; Michael De Lisio; Adam P W Johnston; Ciara E O'Reilly; Stuart M Phillips; Mark A Tarnopolsky; Gianni Parise
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.